Top 10 AuntMinnieEurope stories for 2017
December 27, 2017 -- Today we offer you the top 10 stories of 2017 on AuntMinnieEurope.com. As was the case last year, the single most important issue facing the European imaging community was gadolinium-based contrast agents for MRI, which accounted for four of the 10 articles.  Discuss
MRI guidance can transform prostate radiotherapy
December 26, 2017 -- An international collaboration headed up by the Institute of Cancer Research and the Royal Marsden Hospital in London is investigating the opportunities, benefits, and challenges of MRI-guided adaptive radiotherapy for prostate cancer patients.  Discuss
3D DTI-MRI can suggest weak cervix, pregnancy issues
December 22, 2017 -- Three-dimensional diffusion-tensor MRI (DTI-MRI) examinations of the cervix may have discovered at least one reason why some pregnant women miscarry or go into labor prematurely, according to a U.K. study published online on 11 December.  Discuss
PET/MRI outclasses MRI alone for pelvic cancer recurrence
December 18, 2017 -- PET/MRI can better detect and classify local lesions and distant metastases in women suspected of having recurrent pelvic cancer than MRI alone, according to a study presented at the recent RSNA 2017 annual meeting.  Discuss
U.K. to pull linear gadolinium MRI agents by February
December 15, 2017 -- Two widely used linear gadolinium MRI contrast agents will be pulled from the U.K. market by 1 February, while the use of other linear agents will be restricted to limited indications, according to an announcement by the U.K.'s Medicines and Healthcare products Regulatory Agency.  Discuss
First-in-human data validate MRI-guided radiotherapy
December 5, 2017 -- A research team at the University Medical Center Utrecht in the Netherlands has published details of the first four patient treatments using a new MRI-guided radiotherapy system demonstrates the feasibility and clinical utility of the MRI-linac system.  Discuss
Why EMA's relocation is good news for radiology
December 1, 2017 -- The European Medicines Agency (EMA) is relocating from London to Amsterdam, but does this really matter? Yes it does, Dr. Hildo Lamb wrote in a guest column. He's convinced the move will lead to a host of new opportunities for the medical imaging community.  Discuss
MRI technique may help diagnose migraine headaches
November 30, 2017 -- While painful and often debilitating for patients, migraines can also be difficult to diagnose and differentiate from other types of headaches. An MRI technique may help alleviate that diagnostic challenge, according to research presented on November 28 at the RSNA 2017 meeting in Chicago.  Discuss
PET/CT, MRI foretell developing neurofibromas
November 28, 2017 -- CHICAGO - Researchers from Spain are following the adage "forewarned is forearmed" by using PET/CT and MRI to predict which lesions could progress to malignant neurofibromas. They presented their findings on Sunday at RSNA 2017.  Discuss
Gadolinium: EU nations get 1 year to implement EMA ruling
November 27, 2017 -- The European Commission has adopted the decision of the European Medicines Agency (EMA) on linear gadolinium-based contrast agents, but with one important amendment: European Union (EU) member states will have up to a year to implement the ruling.  Discuss